Marine Drugs · 2020 · 39 citations · 18 references
Life SciencesBiochemistryMicrobiologyBioorganic ChemistryMycologyStructure-activity RelationshipsAntibacterial AgentsAntibiotic ResistanceAntimicrobial PeptidesAntimicrobial Susceptibility TestingMarine Bioactive CompoundsMarine Natural ProductsAbsolute Configuration AssignmentAntibacterial PeptidesBacillus SubtilisBioactive Compounds From Marine SpongesFungal Bioactive CompoundsMarine Sponge MetabolitesMarine-derived Antimicrobial CompoundsSponges-derived Metabolites
Three new aspochracin-type cyclic tripeptides, sclerotiotides M–O (1–3), together with three known analogues, sclerotiotide L (4), sclerotiotide F (5), and sclerotiotide B (6), were obtained from the ethyl acetate extract of the fungus Aspergillus insulicola HDN151418, which was isolated from an unidentified Antarctica sponge. Spectroscopic and chemical approaches were used to elucidate their structures. The absolute configuration of the side chain in compound 4 was elucidated for the first time. Compounds 1 and 2 showed broad antimicrobial activity against a panel of pathogenic strains, including Bacillus cereus, Proteus species, Mycobacterium phlei, Bacillus subtilis, Vibrio parahemolyticus, Edwardsiella tarda, MRCNS, and MRSA, with MIC values ranging from 1.56 to 25.0 µM.
18
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Philip Skehan, Ritsa Storeng, Dominic A. Scudiero et al. · JNCI Journal of the National Cancer Institute · 1990 · 9.8K citations
Medicine, Oncology, Pharmacology +10